N-Nitroso Edoxaban Desmethyl Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs . N-Nitroso Edoxaban Desmethyl Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Desmethyl Impurity chemically represented as N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5- nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2- carboxamido)cyclohexyl)oxalamid .Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Desmethyl Impurity. We supply N-Nitroso Edoxaban Desmethyl Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141239 |
| CAS No | NA |
| Mol.F. | C13H11N3O4 |
| Mol.Wt. | 273.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141240 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141241 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141242 |
| CAS No | NA |
| Mol.F. | C8H7N3O2S |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141243 |
| CAS No | NA |
| Mol.F. | C17H18N4O3S |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141244 |
| CAS No | NA |
| Mol.F. | C18H22N4O4S |
| Mol.Wt. | 390.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141245 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141246 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141247 |
| CAS No | NA |
| Mol.F. | C17H18N4O6S |
| Mol.Wt. | 406.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141248 |
| CAS No | NA |
| Mol.F. | C17H18N4O4 |
| Mol.Wt. | 342.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141249 |
| CAS No | NA |
| Mol.F. | C15H15FN4O4 |
| Mol.Wt. | 334.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141250 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O4 |
| Mol.Wt. | 376.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141251 |
| CAS No | NA |
| Mol.F. | C16H17FN4O2 |
| Mol.Wt. | 316.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141252 |
| CAS No | NA |
| Mol.F. | C17H18N4O5 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141253 |
| CAS No | NA |
| Mol.F. | C19H21N3O4S |
| Mol.Wt. | 387.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141254 |
| CAS No | NA |
| Mol.F. | C13H15BrN2O3 |
| Mol.Wt. | 327.2 |
| INV STATUS | CUSTOM SYNTHESIS |